FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 62 filers reported holding FORTRESS BIOTECH INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $11 | -99.9% | 13,221 | -38.1% | 0.00% | -50.0% |
| Q3 2022 | $18,000 | +63.6% | 21,359 | +57.5% | 0.00% | +100.0% |
| Q2 2022 | $11,000 | -86.7% | 13,560 | -47.3% | 0.00% | -85.7% |
| Q3 2021 | $83,000 | -21.7% | 25,714 | -22.9% | 0.01% | -36.4% |
| Q4 2020 | $106,000 | -54.7% | 33,333 | -42.4% | 0.01% | -72.5% |
| Q3 2020 | $234,000 | +377.6% | 57,872 | +90.7% | 0.04% | +1233.3% |
| Q3 2018 | $49,000 | -30.0% | 30,348 | +98.2% | 0.00% | -25.0% |
| Q1 2018 | $70,000 | +1.4% | 15,311 | -2.2% | 0.00% | +33.3% |
| Q3 2017 | $69,000 | – | 15,657 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,830,000 | $10,264,000 | 2.07% |
| SHIKIAR ASSET MANAGEMENT INC | 345,500 | $926,000 | 0.42% |
| Nantahala Capital Management | 4,424,938 | $11,859,000 | 0.36% |
| FNY Investment Advisers, LLC | 175,000 | $469,000 | 0.27% |
| Telemetry Investments, L.L.C. | 20,376 | $55,000 | 0.15% |
| CPWM, LLC | 406,267 | $1,089,000 | 0.12% |
| 683 Capital Management, LLC | 200,000 | $536,000 | 0.04% |
| B. Riley Wealth Advisors, Inc. | 57,491 | $154,000 | 0.01% |
| Walleye Capital LLC | 15,000 | $40,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 720,803 | $1,932,000 | 0.01% |